Amgen vs Thermo Fisher Scientific
Amgen (AMGN), health care, and Thermo Fisher Scientific (TMO), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Thermo Fisher Scientific is worth $255.8B on the stock market and Amgen $248.3B: Thermo Fisher Scientific is valued at 3% more. Amgen trades at 26.6 times earnings and Thermo Fisher Scientific at 36.4; operating margins in their latest fiscal years were 24.7% and 17.4%. Over the past year Amgen's share price has moved +34.4% and Thermo Fisher Scientific's +20.0%.
Key facts
- Amgen market value
- $248.3B
- Thermo Fisher Scientific market value
- $255.8B
- Amgen P/E
- 26.6
- Thermo Fisher Scientific P/E
- 36.4
- Amgen revenue
- $36.8BFY to 2025-12-31
- Thermo Fisher Scientific revenue
- $44.6BFY to 2025-12-31
- Superinvestors holding both
- 5
Market values as of .
| Measure | Amgen | Thermo Fisher Scientific |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $248.3Blower | $255.8Bhigher |
| Revenue | $36.8Blower | $44.6Bhigher |
| Earnings | $7.7Bhigher | $6.7Blower |
| Employees | 31,500lower | 125,000higher |
| Total assets | $90.6Blower | $110.3Bhigher |
| Valuation | ||
| P/E | 26.6lower | 36.4higher |
| P/S | 6.8higher | 5.7lower |
| P/B | 17.3higher | 4.7lower |
| Dividend yield | 2.15%higher | 0.27%lower |
| Profitability | ||
| Operating margin | 24.7%higher | 17.4%lower |
| Balance sheet | ||
| Net assets | $8.7Blower | $53.4Bhigher |
| Total liabilities | $81.9Bhigher | $56.8Blower |
| Total debt | $54.6Bhigher | $39.4Blower |
| Cash on hand | $9.1Blower | $9.9Bhigher |
| Price change | ||
| Today | -0.71%lower | -0.13%higher |
| 1 year | +34.4%higher | +20.0%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (5)
- Primecap team1.5% / 0.8%
- David Shaw (founder)0.3% / 0.2%
- Ken Fisher0.2% / 0.6%
- Ken Griffin0.1% / 0.2%
- Dodge & Cox team<0.1% / 1.1%
Amgen only (5)
- Bill Smead5.3%
- Howard Gleicher2.6%
- Josef Lakonishok0.4%
- Fred DiSanto0.2%
- Mairs & Power team<0.1%
Thermo Fisher Scientific only (19)
- Nick Train12.4%
- Larry Robbins6.3%
- Wallace Weitz4.9%
- Jeremy Grantham (co-founder)4.3%
- Andreas Halvorsen2.8%
- Harry Burn2.7%
- Temasek2.2%
- Doug Silverman2.0%
- Steven Romick2.0%
- Diamond Hill team1.6%
- Andrew Spokes1.6%
- John Armitage1.4%
- Daniel Sundheim0.7%
- Tom Gayner0.4%
- Baillie Gifford team0.4%
- Stanley Druckenmiller0.2%
- Steve Cohen0.2%
- Joel Greenblatt0.2%
- Paul Tudor Jones0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Amgen / Thermo Fisher Scientific). Who owns AMGN · Who owns TMO
More on Amgen
Further comparisons
Amgen against its closest peers
Thermo Fisher Scientific against its closest peers
Learn
Questions and answers
Which is bigger, Amgen or Thermo Fisher Scientific?
By market value, Thermo Fisher Scientific is the larger: $255.8B against $248.3B for Amgen. By revenue in its latest fiscal year, Thermo Fisher Scientific is the larger: $44.6B against $36.8B for Amgen.
Which has the higher P/E ratio?
Thermo Fisher Scientific: 36.4, against 26.6 for Amgen. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Amgen: 24.7%, against 17.4% for Thermo Fisher Scientific. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Amgen: 2.15%, against 0.27% for Thermo Fisher Scientific. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Amgen: $54.6B, against $39.4B for Thermo Fisher Scientific. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Amgen and Thermo Fisher Scientific?
In their latest 13F filings, Primecap team, David Shaw (founder), Ken Fisher, Ken Griffin and Dodge & Cox team hold both.
Cite this page
Funkfolio, “Amgen vs Thermo Fisher Scientific”, data as of 17 November 2026. https://funkfolio.com/compare/amgn-vs-tmo
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.